Pierre Bédossa

1988–2025 年に発表

別表記
Pierre Bedossa
207
論文数
64,255
被引用数
121
h 指数
202
i10 指数

被引用数

Pierre Bédossa の年別被引用数1983 年: 被引用 2 件1986 年: 被引用 1 件1989 年: 被引用 1 件1991 年: 被引用 6 件1992 年: 被引用 13 件1993 年: 被引用 11 件1994 年: 被引用 22 件1995 年: 被引用 21 件1996 年: 被引用 42 件1997 年: 被引用 75 件1998 年: 被引用 102 件1999 年: 被引用 129 件2000 年: 被引用 148 件2001 年: 被引用 173 件2002 年: 被引用 240 件2003 年: 被引用 274 件2004 年: 被引用 252 件2005 年: 被引用 285 件2006 年: 被引用 329 件2007 年: 被引用 316 件2008 年: 被引用 401 件2009 年: 被引用 302 件2010 年: 被引用 397 件2011 年: 被引用 440 件2012 年: 被引用 377 件2013 年: 被引用 405 件2014 年: 被引用 435 件2015 年: 被引用 425 件2016 年: 被引用 429 件2017 年: 被引用 402 件2018 年: 被引用 391 件2019 年: 被引用 1,218 件2020 年: 被引用 1,867 件2021 年: 被引用 2,407 件2022 年: 被引用 2,392 件2023 年: 被引用 1,872 件2024 年: 被引用 3,558 件2025 年: 被引用 2,100 件2026 年: 被引用 104 件1984〜1985 年は被引用が無いため表示していません1987〜1988 年は被引用が無いため表示していません1990 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,785 件、この内訳の 19.2%中国: 引用元論文 3,159 件、この内訳の 12.7%イタリア: 引用元論文 1,661 件、この内訳の 6.7%フランス: 引用元論文 1,617 件、この内訳の 6.5%イギリス: 引用元論文 1,434 件、この内訳の 5.8%ドイツ: 引用元論文 1,286 件、この内訳の 5.2%日本: 引用元論文 891 件、この内訳の 3.6%スペイン: 引用元論文 851 件、この内訳の 3.4%韓国: 引用元論文 641 件、この内訳の 2.6%オーストラリア: 引用元論文 580 件、この内訳の 2.3%カナダ: 引用元論文 558 件、この内訳の 2.2%オランダ: 引用元論文 451 件、この内訳の 1.8%
0%19.2%その他 28%

分野

  • Medicine83.6%
  • Biochemistry, Genetics and Molecular Biology10.6%
  • Immunology and Microbiology2.1%
  • Neuroscience0.6%
  • Pharmacology, Toxicology and Pharmaceutics0.5%
  • Nursing0.4%
  • その他2.2%

トピック

  • Liver Disease Diagnosis and Treatment21.2%
  • Liver Disease and Transplantation5.7%
  • Hepatitis C virus research4.9%
  • Diet, Metabolism, and Disease3.9%
  • Hepatocellular Carcinoma Treatment and Prognosis3.7%
  • Liver Diseases and Immunity2.8%
  • その他57.8%

共著者

全論文

検索で開く
  1. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Vlad Ratziu, Jacob George - Journal of Hepatology 2020 被引用: 4,410

  2. A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2024 被引用: 1,701

  3. MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Vincent Wai‐Sun Wong, Vlad Ratziu, Yusuf Yılmaz, Zobair M. Younossi - Gastroenterology 2020 被引用: 3,274

  4. NASH limits anti-tumour surveillance in immunotherapy-treated HCC

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Pierre Bédossa, Simon Cockell, Ramy Younes, Michèle Vacca, Fabio Marra, Jörn M. Schattenberg, Michael Allison, Elisabetta Bugianesi, Vlad Ratziu, Tiziana Pressiani, Antonio D’Alessio, Nicola Personeni, Lorenza Rimassa, Ann K. Daly, Bernhard Scheiner, Katharina Pomej, Martha M. Kirstein, Arndt Vogel, Markus Peck‐Radosavljevic, Florian Hucke, Fabian Finkelmeier, Oliver Waidmann, Jörg Trojan, Kornelius Schulze, Henning Wege, Sandra Koch, Arndt Weinmann, Marco Bueter, Fabian Rössler, Alexander Siebenhüner, Sara De Dosso, Jan‐Philipp Mallm, Viktor Umansky, Manfred Jugold, Tom Luedde, Andrea Schietinger, Peter Schirmacher, Brinda Emu, Hellmut G. Augustin, Adrian T. Billeter, Beat P. Müller‐Stich, Hiroto Kikuchi, Dan G. Duda, Fabian Kütting, Dirk‐Thomas Waldschmidt, Matthias Ebert, Nuh N. Rahbari, Henrik E. Mei, Axel Schulz, Marc Ringelhan, Nisar P. Malek, Stephan Spahn, Michael Bitzer, Marina Ruiz de Galarreta, Amaia Lujambio, Jean‐François Dufour, Thomas U. Marron, Ahmed O. Kaseb, Masatoshi Kudo, Yi‐Hsiang Huang, Nabil Djouder, Katharina Wolter, Lars Zender, Parice N. Marche, Thomas Decaens, David J. Pinato, Roland Rad, Joachim C. Mertens, Achim Weber, Kristian Unger ほか 10 名 - Nature 2021 被引用: 1,280

  5. Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

    著者: , , , , , , , , , , , - Gastroenterology 2019 被引用: 1,380

  6. A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2021 被引用: 721

  7. Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH

    著者: , , , , , , , , , , , , , , , , - New England Journal of Medicine 2023 被引用: 442

  8. Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Luna Zaru, Leigh MacConell, Reshma Shringarpure, Stephen A. Harrison, Arun J. Sanyal, Manal F. Abdelmalek, Gary A. Abrams, Humberto Aguilar, Aijaz Ahmed, Elmar Aigner, Guruprasad P. Aithal, Aftab Ala, William Alazawi, Agustı́n Albillos, Michael Allison, Sfa Al-Shamma, Raúl J. Andrade, Pietro Andreoné, M. Angélico, Victor Ankoma‐Sey, Quentin M. Anstee, Rodolphe Anty, Víctor Araya, Juan Ignacio Arenas Ruiz, Perttu Arkkila, Marty Arora, Tarik Asselah, Jennifer Au, Oyekoya T. Ayonrinde, Robert J. Bailey, Maya Balakrishnan, Kiran Bambha, Meena B. Bansal, Sidney Barritt, John Bate, Jorge Beato, Susanne Beckebaum, Jaideep Behari, Pablo Bellot, Ziv Ben Ari, Michael Bennett, Marina Berenguer, Benedetta Terziroli Beretta‐Piccoli, Thomas Berg, Maurizio Bonacini, Lucía Bonet, Brian B. Borg, Marc Bourlière, Jérôme Boursier, William D. Bowman, David Bradley, Marija Branković, Marius Braun, Jean-Pierre Bronowicki, Savino Bruno, Elisabetta Bugianesi, Cindy X. Cai, Amy Calderon, José Luis Calleja Panero, Elizabeth J. Carey, Michal Carmiel, J.A. Carrión, Matthew C. Cave, Cristina Chagas, Tawfik N. Chami, Alan K. Chang, Allan Coates, Jeremy Cobbold, Charlote Costentin, Kathleen E. Corey ほか 288 名 - The Lancet 2019 被引用: 1,213

  9. A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis

    著者: , , , , , , , , , , , , , , - New England Journal of Medicine 2024 被引用: 423

  10. Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Volker Keim, Johannes Wiegand - Journal of Hepatology 2016 被引用: 1,246

  11. FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study

    著者: , , , , , , , , , , , , , , , , , , , , , , - ˜The œLancet. Gastroenterology & hepatology 2020 被引用: 760

  12. Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial

    著者: , , , , , , , , , , , , , , , , , , - ˜The œLancet. Gastroenterology & hepatology 2023 被引用: 235

  13. Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2020 被引用: 454

  14. Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2020 被引用: 514

  15. Biomarkers for staging fibrosis and non-alcoholic steatohepatitis in non-alcoholic fatty liver disease (the LITMUS project): a comparative diagnostic accuracy study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Guruprasad P. Aithal, Jörn M. Schattenberg, Elisabetta Bugianesi, Manuel Romero‐Gómez, Vlad Ratziu, Quentin M. Anstee, Patrick M. Bossuyt - ˜The œLancet. Gastroenterology & hepatology 2023 被引用: 196

  16. An Algorithm for the Grading of Activity in Chronic Hepatitis C

    著者: , - Hepatology 1996 被引用: 4,023

  17. Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anja Geerts, Christophe Moreno, Ulrich Beuers, Peter R. Galle, U. Spengler, Elisabetta Bugianesi, Antonio Craxı̀, M. Angélico, Silvia Fargion, M Voiculescu, Liliana Gheorghe, Liliana Preoțescu, Juan Caballería, Raúl J. Andrade, Javier Crespo, J.L. Callera, Aftab Ala, Guruprasad P. Aithal, George Abouda, Velimir A. Luketic, Mao-Yu Huang, Stuart C. Gordon, Paul J. Pockros, Fred Poordad, Nathan J. Shores, Martin Moehlen, Kiran Bambha, Virginia Clark, Sanjaya K. Satapathy, Samir Parekh, R.K. Reddy, Muhammad Y. Sheikh, Gyöngyi Szabó, John M. Vierling, Timothy E. Foster, Guillermo E. Umpierrez, Chih‐Jen Chang, Terry Box, Juan F. Gallegos‐Orozco - Gastroenterology 2016 被引用: 1,014

  18. Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Patrick M. Bossuyt, Hadi Zafarmand, Yasaman Vali, Jenny Lee, Vlad Ratziu, Karine Clément, Raluca Pais, Detlef Schuppan, Jörn M. Schattenberg, Toni Vidal-Puig, Michèle Vacca, Sergio Rodrigues-Cuenca, Mike Allison, Ioannis Kamzolas, Evangelia Petsalaki, Matej Orešič, Tuulia Hyötyläinen, Aiden McGlinchey, José M. Mato, Óscar Millet, Jean‐François Dufour, Annalisa Berzigotti, Michael Pavlides, Stephen A. Harrison, Stefan Neubauer, Jeremy Cobbold, Ferenc E. Mózes, Salma Akhtar, Rajarshi Banerjee, Matt Kelly, Elizabeth Shumbayawonda, Andrea Dennis, Charlotte Erpicum, Manuel Romero‐Gómez, Emilio Gómez-González, Javier Ampuero, Javier Castell, Rocío Gallego‐Durán, Isabel Fernández-Lizaranzu, Rocío Montero‐Vallejo, M.A. Karsdal, Elisabeth Erhardtsen, Daniel Guldager Kring Rasmussen, Diana Julie Leeming, Mette Juul Fisker, Antonia Sinisi, Kishwar Musa, Fay Betsou, Estelle Sandt, Manuela Tonini, Elisabetta Bugianesi, Chiara Rosso, Angelo Armandi, Fabio Marra, Amalia Gastaldelli, Gianluca Svegliati, Jérôme Boursier, Sven Francque, Luisa Vonghia, Mattias Ekstedt, Stergios Kechagias, Hannele Yki‐Järvinen, Panu K. Luukkonen, Saskia W. C. van Mil, George Papatheodoridis, Helena Cortez‐Pinto, Luca Valenti, Salvatore Petta, Luca Miele, Andreas Geier ほか 35 名 - Journal of Hepatology 2021 被引用: 353

  19. Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hannes Hagström, Camilla Akbari, Masashi Hirooka, Wah‐Kheong Chan, Sanjiv Mahadeva, Ruveena Bhavani Rajaram, Ming‐Hua Zheng, Jacob George, Mohammed Eslam, Salvatore Petta, Grazia Pennisi, Mauro Viganò, Sofia Ridolfo, Guruprasad P. Aithal, Naaventhan Palaniyappan, Dae Ho Lee, Mattias Ekstedt, Patrik Nasr, Christophe Cassinotto, Victor de Lédinghen, Annalisa Berzigotti, Yuly P. Mendoza, Mazen Noureddin, Emily Truong, Céline Fournier‐Poizat, Andreas Geier, Miljen Martić, Theresa Tuthill, Quentin M. Anstee, Stephen A. Harrison, Patrick M. Bossuyt, Michael Pavlides, Quentin M. Anstee, Ann K. Daly, Olivier Govaere, Simon Cockell, Dina Tiniakos, Pierre Bédossa, Alastair D. Burt, Fiona Oakley, Heather J. Cordell, Christopher P. Day, Kristy Wonders, Paolo Missier, Matthew McTeer, Luke Vale, Yemi Oluboyede, Matt Breckons, Patrick M. Bossuyt, Hadi Zafarmand, Yasaman Vali, Jenny Lee, Max Nieuwdorp, Adriaan G. Holleboom, Joanne Verheij, Vlad Ratziu, Karine Clément, Rafael Patiño‐Navarrete, Raluca Pais, Valérie Paradis, Detlef Schuppan, Jörn M. Schattenberg, Rambabu Surabattula, Sudha Rani Myneni, Beate K. Straub, Toni Vidal-Puig, Michèle Vacca, Sergio Rodrigues-Cuenca, Mike Allison, Ioannis Kamzolas ほか 130 名 - ˜The œLancet. Gastroenterology & hepatology 2023 被引用: 187

  20. Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort

    著者: , , , , , , , , , , , , , , - Journal of Hepatology 2021 被引用: 286

  21. Cenicriviroc Lacked Efficacy to Treat Liver Fibrosis in Nonalcoholic Steatohepatitis: AURORA Phase III Randomized Study

    著者: , , , , , , , , , , - Clinical Gastroenterology and Hepatology 2023 被引用: 148

  22. Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients

    著者: , , , , , , , - Hepatology 2012 被引用: 884

  23. Advanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic Screening

    著者: , , , , , , , , , , , , , , , , , , - Diabetes Care 2020 被引用: 347

  24. An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marta B. Afonso, Ramy Younes, Yuichiro Amano, Scott L. Friedman, Shuang Wang, Dipankar Bhattacharya, Eric J. Simon, Valérie Paradis, Alastair D. Burt, Ioanna Maria Grypari, Susan Davies, Ann Driessen, Hiroaki Yashiro, Susanne Elisabeth Pors, M Andersen, Michael Feigh, Carla Yunis, Pierre Bédossa, Michelle Stewart, Heather Cater, Sara Wells, Jörn M. Schattenberg, Quentin M. Anstee, The LITMUS Investigators, Quentin M. Anstee, Ann K. Daly, Simon Cockell, Dina Tiniakos, Pierre Bédossa, Alastair D. Burt, Fiona Oakley, Heather J. Cordell, Christopher P. Day, Kristy Wonders, Paolo Missier, Matthew McTeer, Luke Vale, Yemi Oluboyede, Matt Breckons, Jo Boyle, Patrick M. Bossuyt, Hadi Zafarmand, Yasaman Vali, Jenny Lee, Max Nieuwdorp, Adriaan G. Holleboom, Athanasios Angelakis, Joanne Verheij, Vlad Ratziu, Karine Clément, Rafael Patiño‐Navarrete, Raluca Pais, Valérie Paradis, Detlef Schuppan, Jörn M. Schattenberg, Rambabu Surabattula, Sudha Rani Myneni, Yong Ook Kim, Beate K. Straub, Antonio Vidal-Puig, Michèle Vacca, Sergio Rodrigues-Cuenca, Mike Allison, Ioannis Kamzolas, Evangelia Petsalaki, Mark Campbell, Chris Lelliott, Susan Davies, Matej Orešič, Tuulia Hyötyläinen ほか 138 名 - Nature Metabolism 2024 被引用: 229